Bonmente

Tap a star to rate

Bonmente is a telepsychiatry platform operating in four western US states that brings psychiatry, therapy, and medication management into one streamlined practice. Headquartered in Long Beach, California, the company is staffed by physicians, nurse practitioners, and licensed therapists who specialize in mental health treatment. The platform emphasizes making psychiatric care "easy and accessible" through video appointments and integrated treatment planning, so patients can see a provider, adjust medications, and attend therapy sessions all within the same practice rather than coordinating across multiple offices.

How Treatment Works

A patient starts by enrolling and scheduling an initial appointment. Bonmente does not publish specific wait times on its public pages, though it emphasizes availability and convenience as a selling point. Once scheduled, you meet your provider via secure video, no travel required, no wait-room time. The initial session is a psychiatric evaluation, where the provider assesses your symptoms, concerns, and lifestyle to arrive at a diagnosis and build a treatment plan.

From that evaluation, your provider crafts a personalized treatment plan "as unique as you are" and "based on leading evidence and best practices." The plan may include medication management alone, therapy alone, or both together depending on what you and your provider agree serves you best. Bonmente's key marketing point is that you do not bounce between separate psychiatrists and therapists in separate clinics, instead, your psychiatrist and therapist are part of the same practice, they communicate, and your plan is coordinated.

Medication management involves regular follow-up visits where the provider reviews how medications are working, monitors for side effects, and adjusts dosing as needed. Bonmente does not name a standard visit frequency, but the language around "ensure you're on track to feeling your best" implies ongoing check-ins rather than one-time prescriptions.

Therapy is offered by licensed therapists and is described as "a safe space to breathe, cry, get angry, and work through the tough stuff." The site says therapy is "tailored to YOU" but does not specify modalities (CBT, DBT, psychodynamic, etc.) or how therapists are matched to patients.

Psychiatric evaluation is described as the process to "get a clear picture of the problem and develop a collaborative solution." The site emphasizes working together with your provider to refine your care as your needs change. The telehealth platform itself uses secure, encrypted video, and all records are handled per HIPAA requirements.

What the Pages Prove

Bonmente operates in four states: California, Florida, Arizona, and Washington. The homepage states, "We are currently providing care throughout California, Florida, Arizona, and Washington." There is no mention of plans to expand to other states, though no statement rules it out either.

The company says it is "Trusted by 20,000+ customers," a scale measure mentioned on the homepage. No breakdown is given for how many customers are in each state or condition category.

Conditions explicitly listed across the site include anxiety, depression, ADHD, sleep disorders, postpartum depression, PTSD, bipolar disorder, schizophrenia, personality disorders, and OCD. On the "What We Treat" page, the company notes that anxiety disorders affect "more than 40 million adults and 7% of children in the United States" and depression affects "more than 280 million people worldwide," but these are general health facts, not Bonmente-specific outcomes.

The site notes that postpartum depression affects "an estimated one in eight women" and poses risks to both mother and baby, but again this is context rather than Bonmente-specific data. For sleep disorders, the site states they "impact physical health and can lead to mood disturbances" but offers no information about how many Bonmente patients have sleep issues or what treatment looks like specifically.

Services listed include psychiatric evaluation, therapy, medication management, ADHD testing, GLP-1 and GIP weight control (a medication-assisted weight loss service), electronic prescriptions, telepsychiatry, concierge support, and medication-assisted treatment. The company emphasizes HIPAA compliance and secure telehealth.

Bonmente's providers are described as "physicians, nurse practitioners, and therapists" who are "specially trained to provide evidence-based treatments." No credentials are listed for individual providers on the public pages. The site mentions that the practice is "physician-owned," which it frames as ethically important ("What happens when financial priorities compete with clinical priorities?"), but no details about the company's ownership structure or founder history appear on the pages.

What Bonmente Does Not Describe

Insurance and payment information is entirely absent from the captured pages. There is no mention of which insurance plans Bonmente accepts, copay ranges, or whether they bill insurance directly or require out-of-pocket payment. The site does not state whether Bonmente accepts Medicaid or Medicare. For someone without insurance, no pricing is disclosed.

Wait times are not stated. The site emphasizes convenience and accessibility, but does not say how long a new patient typically waits for an initial appointment or how quickly follow-ups can be scheduled.

Medication policies are not detailed. The site does not specify which psychiatric medications Bonmente can or cannot prescribe, whether controlled substances are available, or any restrictions on medication categories. This is particularly relevant to telepsychiatry, where many states and platforms have rules about prescribing certain drugs remotely.

ADHD testing is listed as a service, but the process, timeline, and cost are not explained. It is unclear whether testing is conducted by the psychiatrist or by a separate provider, or whether a positive diagnosis leads to medication, therapy, referral for coaching, or some combination.

The GLP-1 and GIP weight control service is mentioned prominently on the homepage but barely explained. There is no description of whether this is offered alone or only to people already in psychiatric treatment, what the cost is, which medications are available, or who qualifies.

Individual provider bios, credentials, or specializations are not published on the main site, so a patient cannot see which providers have experience with a specific condition, take a particular insurance, or offer certain modalities.

Who It Fits and Who It Does Not

Bonmente fits someone in California, Florida, Arizona, or Washington who wants to consolidate psychiatric and therapy care in one practice. It appeals to someone who has had fragmented care, a different psychiatrist and therapist who did not communicate, and wants coordination instead.

The emphasis on personalized, collaborative treatment plans appeals to someone who wants agency in shaping their care rather than being handed a diagnosis and a prescription. The all-in-one model also appeals to someone who is anxious about juggling appointments and prefers simplicity.

The postpartum depression focus is explicit enough that someone struggling in the perinatal window could feel seen and prioritized. The service's mention of sleep disorders, ADHD, and a range of psychiatric conditions means there is a path for many conditions, though without modality details it is unclear whether specialized approaches (like DBT for borderline or prolonged exposure for PTSD) are available.

Bonmente does not fit someone in any state outside its four, or someone on Medicaid or Medicare without more information. Someone shopping primarily by price will find no published costs to compare. A patient wanting a specific provider credential, specialization, or therapeutic modality cannot preview who is available without calling or going through the enrollment flow.

The lack of insurance information is a significant gap for someone whose employer plan is not mentioned on Bonmente's site. Until pricing and insurance are disclosed, it is difficult to evaluate affordability.

More in Online Psychiatry and Medication

See all